Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8e43b4ca6b41ce9f54c9a895d474c81a |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-465 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07G99-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P1-06 |
filingDate |
1996-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fb4d1151a4a092eab80be1e41d4ccf2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e407296d1b75d6be008fc8484abf6c45 |
publicationDate |
1998-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-H1081692-A |
titleOfInvention |
Novel compounds FE35A and B, production method thereof and use thereof |
abstract |
(57) [Problem] To provide a novel compound having antitumor activity. The compounds FE35A and FE35B are Streptomyces rochei 3218-GM2 strain (Life FERM P-15720). FE35A is a compound having a molecular weight of 549 and a molecular formula of C 30 H 31 NO 9 , and FE35B is a compound having a molecular weight of 577 and a molecular formula of C 31 H 31 NO 10 . |
priorityDate |
1996-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |